Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel Diagnostics (NCT06114888)
Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: a Feasibility Randomized Controlled Trial of a Diagnostic Intervention
🩺 Plain-English Summary (8th-Grade Level)
Children are commonly hospitalized because of community-acquired pneumonia. Despite the fact that many of these children have viral disease, a majority is treated with antibiotics. These antibiotics will not accelerate recovery in those with viral pneumonia and can cause harm. We are interested in exploring whether the MeMed BV - a composite biomarker assay - could be used to improve antibiotic prescribing in these children by identifying those who likely have viral disease. This proposal describes a feasibility randomized trial of this diagnostic intervention.
Who can join: Review the eligibility criteria below.
Location: McMaster Children's Hospital — Hamilton, Ontario
Age range: 6 Months to 18 Years
🧪 Interventions in This Study
- MeMed BV + Usual Care (DIAGNOSTIC_TEST)
- Usual Care Alone (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- McMaster Children's Hospital — Hamilton, Ontario
📞 Contact the Study Coordinator
Phone: (905) 521-2100
Email: pernica@mcmaster.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Community-acquired Pneumonia
- AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia — Chicago, Illinois
- Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) — Mobile, Alabama
- Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams — Scottsdale, Arizona
- Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia. — Montreal, Quebec
Explore by condition: All Community-acquired Pneumonia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.